NCT05609227

Brief Summary

The aim of this interventional study is to determine the effect of the mobile application on quality of life and supportive care in patient undergoing stem cell transplantation.The main questions it aims to answer are:

  1. 1.What is the effect of the education given with the mobile application on the quality of life of stem cell transplant patients?
  2. 2.What is the effect of the education given with the mobile application on supportive care of stem cell transplant patients?
  3. 3.What is the effect of the education given with the mobile application on anxiety levels of stem cell transplant patients? In the study, patients will be randomized into the group in which standard processes are applied and the group trained by the mobile application.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 27, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 8, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

November 8, 2022

Status Verified

November 1, 2022

Enrollment Period

10 months

First QC Date

October 27, 2022

Last Update Submit

November 1, 2022

Conditions

Keywords

stem cell transplantationmobile applicationbone marrow transplantquality of lifesupportive care

Outcome Measures

Primary Outcomes (3)

  • quality of functionality

    Functional Assessment of Cancer Therapy-Bone Marrow Transplant (4th version) (Change from baseline to the 30th and 90th days will be assessed).

    Baseline and 90th days

  • supportive care

    James Supportive Care Screening (Change from baseline to the 30th and 90th days will be assessed).

    Baseline and 90th days

  • anxiety

    Distress thermometer (Change from baseline to the 30th and 90th days will be assessed).

    Baseline and 90th days

Study Arms (2)

mobile application

EXPERIMENTAL

Participants will get a mobile application containing information about information about all stages of stem cell transplantation process (pre, during and post).

Other: mobile application

Control

NO INTERVENTION

Participants will receive routine care.

Interventions

The application, compatible with IOS and android systems for patients candidate for stem cell transplantation, could be applied whenever needed information relating to transplantation process.

mobile application

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing hematopoietic stem cell transplantation (autologous or allogeneic) for the first time
  • Patients aged18 years or older,
  • Patients able to communicate in Turkish as well as reading and writing.
  • Those whose physical and mental conditions are suitable for participating in the research,
  • Patients volunteered to participate in the study.

You may not qualify if:

  • Being illiterate
  • Patients not having a smartphone
  • Patients not being able to use mobile application

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi

Ankara, Yenimahalle, 06200, Turkey (Türkiye)

Location

Related Publications (3)

  • Rozwadowski M, Dittakavi M, Mazzoli A, Hassett AL, Braun T, Barton DL, Carlozzi N, Sen S, Tewari M, Hanauer DA, Choi SW. Promoting Health and Well-Being Through Mobile Health Technology (Roadmap 2.0) in Family Caregivers and Patients Undergoing Hematopoietic Stem Cell Transplantation: Protocol for the Development of a Mobile Randomized Controlled Trial. JMIR Res Protoc. 2020 Sep 18;9(9):e19288. doi: 10.2196/19288.

    PMID: 32945777BACKGROUND
  • Larson JL, Rosen AB, Wilson FA. The Effect of Telehealth Interventions on Quality of Life of Cancer Patients: A Systematic Review and Meta-Analysis. Telemed J E Health. 2018 Jun;24(6):397-405. doi: 10.1089/tmj.2017.0112. Epub 2017 Nov 7.

    PMID: 29112484BACKGROUND
  • Moradian S, Voelker N, Brown C, Liu G, Howell D. Effectiveness of Internet-based interventions in managing chemotherapy-related symptoms in patients with cancer: a systematic literature review. Support Care Cancer. 2018 Feb;26(2):361-374. doi: 10.1007/s00520-017-3900-8. Epub 2017 Sep 25.

    PMID: 28948360BACKGROUND

MeSH Terms

Conditions

Hematologic Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants will be stratified according to type of planned transplantation by preparatory outpatient clinic nurse; then will randomly assigned to two groups either intervention or control. The intervention group will get a mobile application developed compatible with IOS or android systems, containing information about the stem cell transplantation process, stem cell transplantation and nutrition, lifestyle recommendations, and answering possible questions of the patients and their relatives. The control group will receive standard care. The data of both groups will be collected on the first day of hospitalization, at controls during the first and third month.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MSc

Study Record Dates

First Submitted

October 27, 2022

First Posted

November 8, 2022

Study Start

March 1, 2022

Primary Completion

December 30, 2022

Study Completion

March 1, 2023

Last Updated

November 8, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations